By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Benzodiazepine > Lorazepam

Lorazepam

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|603 words

Lorazepam Drug Profile

What is Lorazepam?

Lorazepam is a prescription medication that belongs to a class of drugs called benzodiazepines, which are central nervous system depressants. It is primarily used to treat anxiety disorders, insomnia, and seizures by producing a calming effect on the brain and nervous system. Lorazepam works quickly and is often prescribed for short-term relief of severe anxiety symptoms.

Uses

Lorazepam has several FDA-approved medical uses:

  • Anxiety disorders: Treatment of anxiety disorders and short-term relief of anxiety symptoms, including anxiety associated with depression
  • Insomnia: Short-term treatment of sleep disorders, particularly when anxiety is a contributing factor
  • Seizure control: Management of status epilepticus (prolonged seizures) and as adjunctive therapy for certain types of epilepsy
  • Pre-operative sedation: Used before medical procedures to reduce anxiety and produce sedation
  • Alcohol withdrawal: Management of acute alcohol withdrawal symptoms under medical supervision

How it works

Lorazepam enhances the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain. By binding to GABA receptors, lorazepam increases GABA’s natural calming effects, which reduces abnormal brain activity that can cause anxiety, seizures, and muscle tension. This mechanism produces the medication’s sedative, anti-anxiety, and anticonvulsant effects.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness and sedation
  • Dizziness and unsteadiness
  • Weakness and fatigue
  • Confusion or memory problems
  • Headache
  • Nausea
  • Blurred vision
  • Changes in appetite

Serious side effects requiring immediate medical attention:

  • Severe respiratory depression or difficulty breathing
  • Loss of consciousness or extreme sedation
  • Severe confusion or memory loss
  • Paradoxical reactions (increased agitation or aggression)
  • Signs of allergic reaction (rash, swelling, severe dizziness)

Warnings and precautions

  • Addiction potential: Lorazepam can be habit-forming and should only be used as prescribed. Risk of physical dependence increases with prolonged use and higher doses.
  • Pregnancy and breastfeeding: Classified as pregnancy category D – may cause harm to unborn babies. Can pass into breast milk and affect nursing infants.
  • Elderly patients: Increased sensitivity to side effects, particularly sedation, confusion, and falls. Lower doses typically recommended.
  • Liver and kidney impairment: Dosage adjustments may be necessary in patients with hepatic or renal dysfunction as drug clearance can be reduced.
  • Respiratory conditions: Use with extreme caution in patients with sleep apnea, chronic obstructive pulmonary disease, or other breathing problems.

Interactions

Lorazepam can interact with numerous medications and substances:

  • Alcohol: Increases sedation and respiratory depression risk – potentially dangerous combination
  • Opioid pain medications: Combined use significantly increases risk of severe sedation, respiratory depression, and death
  • Other central nervous system depressants: Including other benzodiazepines, barbiturates, and sleep medications – additive sedative effects
  • Antihistamines: May increase drowsiness and cognitive impairment
  • Muscle relaxants: Enhanced sedation and muscle weakness
  • Antidepressants: Some may increase lorazepam levels or enhance sedative effects
  • Valerian and kava supplements: May increase sedation and should be avoided
  • Grapefruit juice: May affect lorazepam metabolism and increase drug levels

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated:

  • Anxiety: 1-3 mg daily, divided into 2-3 doses, with the largest dose typically taken at bedtime
  • Insomnia: 2-4 mg at bedtime
  • Pre-operative sedation: 2-4 mg administered before the procedure

Elderly or debilitated patients typically start with lower doses (0.5-1 mg daily). Treatment duration should be as short as possible, generally not exceeding 2-4 weeks for anxiety or insomnia. Dosage must be individualized and determined by a healthcare provider based on patient response, medical history, and concurrent medications. Gradual dose reduction is necessary when discontinuing to prevent withdrawal symptoms.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lorazepam." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/lorazepam/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Child Mortality Progress Stalls: 60 Countries Risk Missing 2030 UN Targets

New BMJ analysis reveals 60 countries unlikely to meet UN child survival…

Scientists Discover Master Clock That Controls Biological Growth and Development

Scientists have identified a genetic master clock that controls biological development timing.…

Brain immune cells reveal why some people resist dementia despite tau tangles

New Nature Medicine research reveals how brain immune cells determine whether people…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Clonazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Alprazolam

By
Prof. Giorgi Pkhakadze
02/06/2026

Midazolam

By
Prof. Giorgi Pkhakadze
02/06/2026

Temazepam

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up